| Dr Sean Michael Kelly, DO | |
|
606 Beech St, Township Of Washington, NJ 07676-4332 | |
| (201) 280-4458 | |
| Not Available |
| Full Name | Dr Sean Michael Kelly |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 606 Beech St, Township Of Washington, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063851509 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital Of Suffern | Suffern, NY | Hospital |
| Riverview Medical Center | Red bank, NJ | Hospital |
| St Anthony Community Hospital | Warwick, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospitalist Physicians Of New Jersey Pa | 3476859927 | 112 |
| Rockland Physician Medicine Services Pc | 1951731991 | 36 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago
| Entity Name | Medexpress Urgent Care - New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205183894 PECOS PAC ID: 6103076526 Enrollment ID: O20121022000045 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago
| Entity Name | Hospitalist Physicians Of New Jersey Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588021851 PECOS PAC ID: 3476859927 Enrollment ID: O20160309000541 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago
| Entity Name | North Bergen Hospitalists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689028946 PECOS PAC ID: 6002107976 Enrollment ID: O20160623001331 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago
| Entity Name | Inhospital Physicians Corp Of New Jersey, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336625425 PECOS PAC ID: 2264781780 Enrollment ID: O20180816002176 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago
| Entity Name | Medexpress Urgent Care - Northern New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487185369 PECOS PAC ID: 4183965122 Enrollment ID: O20190401001534 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sean Michael Kelly, DO 606 Beech St, Township Of Washington, NJ 07676-4332 Ph: (201) 280-4458 | Dr Sean Michael Kelly, DO 606 Beech St, Township Of Washington, NJ 07676-4332 Ph: (201) 280-4458 |
News Archive
Antares Pharma, today announced the filing of a New Drug Application with the U.S. Food and Drug Administration for Anturol Gel in patients with overactive bladder.
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
Blue Cross and Blue Shield in Michigan won a hospital pricing antitrust case. In Minnesota, nonprofit insurer UCare prepares to return $8 million to the state while Blue Cross and Blue Shield of Minnesota's profit rose 20 percent in 2011.
› Verified 8 days ago